Provides health products and pharmaceutical distribution services in China, focusing on expanding healthcare access.
Qilian International Holding Group Limited is a prominent player in China's pharmaceutical and agricultural sectors, specializing in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and related products. Established in 2019 and headquartered in Jiuquan, the People's Republic of China, Qilian International is committed to advancing healthcare and agricultural solutions through its diverse portfolio.
The company's offerings encompass a wide range of pharmaceutical products and derivatives. Qilian International is renowned for its licorice-based medications, including Gan Di Xin, recognized for its antitussive and expectorant properties, and Qilian Shan Licorice Extract, a crucial ingredient utilized by pharmaceutical companies in the production of traditional licorice tablets. Additionally, Qilian International manufactures oxytetracycline tablets and APIs, essential for preventing and treating diseases in livestock and humans alike, underscoring its significant role in both veterinary and human healthcare sectors.
Beyond pharmaceuticals, Qilian International is dedicated to enhancing agricultural productivity with its Xiongguan organic and organic-inorganic compound fertilizers. These innovative products are designed to improve crop yields, enhance soil fertility, and promote sustainable agricultural practices. With a strategic focus on quality and innovation, Qilian International Holding Group Limited continues to strengthen its position as a leader in both pharmaceutical manufacturing and agricultural enhancement in China and beyond.